01-17407. Animal Drugs, Feeds, and Related Products; Tylosin; Withdrawal of Approval of NADAs  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions that reflect approval of two new animal drug applications (NADAs) listed below. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of the NADAs.

    DATES:

    This rule is effective July 23, 2001.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-5593.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Heinold Feeds, Inc., P.O. Box 377, Kouts, IN 46347, has requested that FDA withdraw approval of NADA 95-628 for Tylosin® Antibiotic Premix and NADA 127-506 for Tylan® Sulfa-G Premixes because the products are no longer manufactured or marketed.

    Following the withdrawal of approval of these NADAs, Heinold Feeds, Inc., is no longer the sponsor of any approved applications. Therefore, 21 CFR 510.600(c) is amended to remove entries for this sponsor.

    As provided below, the animal drug regulations are amended to reflect the withdrawal of approvals.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects

    21 CFR Part 510

    • Administrative practice and procedure
    • Animal drugs
    • Labeling
    • Reporting and recordkeeping requirements

    21 CFR Part 558

    • Animal drugs
    • Animal feeds
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 558 are amended as follows:

    End Amendment Part Start Part

    PART 510—NEW ANIMAL DRUGS

    End Part

    1. The authority citation for 21 CFR part 510 continues to read as follows:

    Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    End Authority
    [Amended]

    2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for “Heinold Feeds, Inc.,” and in the table in paragraph (c)(2) by removing the entry for “043727”.

    Start Part

    PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

    End Part

    3. The authority citation for 21 CFR part 558 continues to read as follows:

    Start Authority

    Authority: 21 U.S.C. 360b, 371.

    End Authority
    [Amended]

    4. Section 558.625 Tylosin is amended by removing and reserving paragraph (b)(9).

    [Amended]

    5. Section 558.630 Tylosin and sulfamethazine is amended in paragraph (b)(10) by removing “043727,”; and by removing “and 051359, 053389” and by adding in its place “051359, and 053389”.

    Start Signature

    Dated: July 2, 2001.

    Stephen F. Sundlof,

    Director, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 01-17407 Filed 7-10-01; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
7/23/2001
Published:
07/11/2001
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
01-17407
Dates:
This rule is effective July 23, 2001.
Pages:
36162-36162 (1 pages)
PDF File:
01-17407.pdf
CFR: (3)
21 CFR 510.600
21 CFR 558.625
21 CFR 558.630